These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10348808)

  • 1. Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis.
    Kakkar T; Boxenbaum H; Mayersohn M
    Drug Metab Dispos; 1999 Jun; 27(6):756-62. PubMed ID: 10348808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a minimal experimental design for determination of enzyme kinetic parameters and inhibition mechanism.
    Kakkar T; Pak Y; Mayersohn M
    J Pharmacol Exp Ther; 2000 Jun; 293(3):861-9. PubMed ID: 10869386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear parameter estimation of rational biokinetic functions.
    Doeswijk TG; Keesman KJ
    Water Res; 2009 Jan; 43(1):107-16. PubMed ID: 19004464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of enzyme kinetic parameters and differentiation between various mechanisms by means of a non-linear least squares method].
    Haerlin R; Steinijans V
    Arzneimittelforschung; 1978; 28(2):292-7. PubMed ID: 580396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of the estimation of enzyme kinetic parameters by fitting reaction curve to the integrated Michaelis-Menten rate equations of different predictor variables.
    Liao F; Zhu XY; Wang YM; Zuo YP
    J Biochem Biophys Methods; 2005 Jan; 62(1):13-24. PubMed ID: 15656940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening of enzyme inhibitors: automatic determination of tight-binding inhibition constants.
    Kuzmic P; Sideris S; Cregar LM; Elrod KC; Rice KD; Janc JW
    Anal Biochem; 2000 May; 281(1):62-7. PubMed ID: 10847611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design.
    Murphy DJ
    Anal Biochem; 2004 Apr; 327(1):61-7. PubMed ID: 15033511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive interactions of drugs with their targets: a computerized improvement of Dixon's algorithm.
    Mattioni D; Cheminant M; Labia R
    Int J Clin Pharmacol Res; 1991; 11(2):51-4. PubMed ID: 1879989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress curve analysis for enzyme and microbial kinetic reactions using explicit solutions based on the Lambert W function.
    Goudar CT; Harris SK; McInerney MJ; Suflita JM
    J Microbiol Methods; 2004 Dec; 59(3):317-26. PubMed ID: 15488275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein interference in bovine plasmin assays using a synthetic substrate.
    Bastian ED; Brown RJ; Ernstrom CA
    J Dairy Sci; 1991 Dec; 74(12):4119-24. PubMed ID: 1838556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved rearrangement of the integrated Michaelis-Menten equation for calculating in vivo kinetics of transport and metabolism.
    Russell RW; Drane JW
    J Dairy Sci; 1992 Dec; 75(12):3455-64. PubMed ID: 1474212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fast nonlinear method for parametric imaging of myocardial perfusion by dynamic (13)N-ammonia PET.
    Golish SR; Hove JD; Schelbert HR; Gambhir SS
    J Nucl Med; 2001 Jun; 42(6):924-31. PubMed ID: 11390558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition.
    Yang J; Jamei M; Yeo KR; Tucker GT; Rostami-Hodjegan A
    Eur J Pharm Sci; 2007 Jul; 31(3-4):232-41. PubMed ID: 17512176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy).
    Van LM; Heydari A; Yang J; Hargreaves J; Rowland-Yeo K; Lennard MS; Tucker GT; Rostami-Hodjegan A
    J Psychopharmacol; 2006 Nov; 20(6):834-41. PubMed ID: 16478752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regression.
    Ernest CS; Hooker AC; Karlsson MO
    Pharm Res; 2010 May; 27(5):866-77. PubMed ID: 20221897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of procedures for determining Michaelis-Menten parameters together with their standard deviations using simulated measurement series].
    Hoppe H; Cumme GA
    Acta Biol Med Ger; 1978; 37(8):1177-84. PubMed ID: 749454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of respiratory gas exchange: a comparative study of linear and nonlinear model-based estimation techniques.
    Brandes A; Bruni C; Granato L
    IEEE Trans Biomed Eng; 2006 Jul; 53(7):1241-9. PubMed ID: 16830928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general.
    Boxenbaum H
    J Pharm Pharm Sci; 1999; 2(2):47-52. PubMed ID: 10952769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nonlinearities and uncorrelated or correlated errors in realistic simulated data on the prediction abilities of augmented classical least squares and partial least squares.
    Melgaard DK; Haaland DM
    Appl Spectrosc; 2004 Sep; 58(9):1065-73. PubMed ID: 15479523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of competitive enzyme inhibition with end point progress curve data.
    Gutiérrez OA; Danielson UH
    Anal Biochem; 2006 Nov; 358(1):11-9. PubMed ID: 16978578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.